CSI300 Index Rebalance: 25 Changes as Long/Short Trade Does Well
There are 25 changes to the CSI300 Index that will be implemented at the close on 11 June. One-way turnover is 3.67% and the adds have outperformed...
491 Views
Pre-IPO Apollomics - Concerns on Competition and Commercialization Despite Some Promising Products
This article provided insights on its major products in the pipeline in terms of competitive landscape, strength and challenges, as well as...
612 Views
Bio-Thera Solutions (688177.CH) - What's Next for Bio-Thera After R&D Setbacks and Years of Losses?
The article analyzed the concerns after the suspension of R&D of its three core products, the challenges of its listed product Qletli,and also the...
253 Views
Genor Biopharma (6998.HK) - Here Is Why the Stock Price Decreased by About 50%
This article analyzed the concerns of Genor Biopharma in terms of core products, competitive landscape, industry characteristics and the potential...
298 Views
ECM Weekly (21 February 2021) - Tencent Lock-Up Expiry, SciClone Pharma, Joinn Lab, Bairong, Betta
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
570 Views